Casdin Eli 4

4 · GeneDx Holdings Corp. · Filed Jun 23, 2025

Form 4

Period: 2025-06-18

Director10% Owner

Transactions

Award
Restricted Stock Unit
2025-06-18+3,576→ 3,576 total
→ Class A Common Stock (3,576 underlying)
Exercise/Conversion
Restricted Stock Unit
2025-06-18−12,924→ 0 total
→ Class A Common Stock (12,924 underlying)
Exercise/Conversion
Class A Common Stock
2025-06-18+12,924→ 20,518 total

Holdings

Footnotes (5)

[F1]Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
[F2]The securities are owned directly by Casdin Partners Master Fund, L.P. (the "Master Fund") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC, the investment adviser to the Master Fund ("Casdin"), (ii) Casdin Partners GP, LLC, the general partner of the Master Fund (the "GP"), and (iii) Eli Casdin, the managing member of Casdin and the GP.
[F3]The securities are owned directly by the GP, the general partner of Casdin Partners Master Fund, L.P. and may be deemed to be indirectly beneficially owned by Eli Casdin, the managing member of the GP.
[F4]The securities are owned directly by CMLS Holdings LLC ("CMLS Holdings"). The Board of Managers of CMLS Holdings includes Eli Casdin, who, as a member of the Board of Managers of CMLS Holdings, shares voting and investment discretion with respect to the common stock held by CMLS Holdings.
[F5]The RSUs shall vest the earlier of (a) the date of the next annual meeting of the Issuer's shareholders following the grant date, and (b) the first anniversary of the grant date, subject to the Reporting Person continuing to provide services to the Issuer through each vesting date.

Documents

1 file